Lifeline Drugs & Pharma (Delisted) stake sales and purchases

BSE: 506113Retailing

Last traded ₹134.40 on 27 Aug 2015

Delisted on 23 Nov 2023.

Lifeline Drugs & Pharma stake sales and purchases

All 4 disclosures on record.

  1. Sep 2010

    • SoldKirti M Kanakia20.54% of the company49,300 shares30 Sep 2010 · filed under the 1997 takeover rules · Share purchase agreement
    • SoldOm Shree Pharmachem Pvt Ltd0.96% of the company2,300 shares30 Sep 2010 · filed under the 1997 takeover rules · Share purchase agreement
    • SoldNikunj K Kanakia20.67% of the company49,610 shares30 Sep 2010 · filed under the 1997 takeover rules · Share purchase agreement
    • AcquiredIvory Consultants Pvt Ltd42.17% of the company1,01,210 sharesholds 42.17% after30 Sep 2010 · filed under the 1997 takeover rules · Share purchase agreement

The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.